Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells
- PMID: 19720798
- PMCID: PMC2780878
- DOI: 10.2337/db09-0277
Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells
Abstract
Objective: Chemerin is an adipokine that affects adipogenesis and glucose homeostasis in adipocytes and increases with BMI in humans. This study was aimed at investigating the regulation of chemerin release and its effects on glucose metabolism in skeletal muscle cells.
Research design and methods: Human skeletal muscle cells were treated with chemerin to study insulin signaling, glucose uptake, and activation of stress kinases. The release of chemerin was analyzed from in vitro differentiated human adipocytes and adipose tissue explants from 27 lean and 26 obese patients.
Results: Human adipocytes express chemerin and chemokine-like receptor 1 (CMKLR1) differentiation dependently and secrete chemerin (15 ng/ml from 10(6) cells). This process is slightly but significantly increased by tumor necrosis factor-alpha and markedly inhibited by >80% by peroxisome proliferator-activated receptor-gamma activation. Adipose tissue explants from obese patients are characterized by significantly higher chemerin secretion compared with lean control subjects (21 and 8 ng from 10(7) cells, respectively). Chemerin release is correlated with BMI, waist-to-hip ratio, and adipocyte volume. Furthermore, higher chemerin release is associated with insulin resistance at the level of lipogenesis and insulin-induced antilipolysis in adipocytes. Chemerin induces insulin resistance in human skeletal muscle cells at the level of insulin receptor substrate 1, Akt and glycogen synthase kinase 3 phosphorylation, and glucose uptake. Furthermore, chemerin activates p38 mitogen-activated protein kinase, nuclear factor-kappaB, and extracellular signal-regulated kinase (ERK)-1/2. Inhibition of ERK prevents chemerin-induced insulin resistance, pointing to participation of this pathway in chemerin action.
Conclusions: Adipocyte-derived secretion of chemerin may be involved in the negative cross talk between adipose tissue and skeletal muscle contributing to the negative relationship between obesity and insulin sensitivity.
Figures
![FIG. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780878/bin/zdb0120959280001.gif)
![FIG. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780878/bin/zdb0120959280002.gif)
![FIG. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780878/bin/zdb0120959280003.gif)
![FIG. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780878/bin/zdb0120959280004.gif)
![FIG. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780878/bin/zdb0120959280005.gif)
![FIG. 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780878/bin/zdb0120959280006.gif)
![FIG. 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780878/bin/zdb0120959280007.gif)
![FIG. 8.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780878/bin/zdb0120959280008.gif)
Similar articles
-
Chemerin is a novel adipokine associated with obesity and metabolic syndrome.Endocrinology. 2007 Oct;148(10):4687-94. doi: 10.1210/en.2007-0175. Epub 2007 Jul 19. Endocrinology. 2007. PMID: 17640997
-
Chemerin induces insulin resistance in rat cardiomyocytes in part through the ERK1/2 signaling pathway.Pharmacology. 2014;94(5-6):259-64. doi: 10.1159/000369171. Epub 2014 Nov 28. Pharmacology. 2014. PMID: 25471554
-
Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism.J Biol Chem. 2007 Sep 21;282(38):28175-88. doi: 10.1074/jbc.M700793200. Epub 2007 Jul 16. J Biol Chem. 2007. PMID: 17635925
-
Secreted proteins from adipose tissue and skeletal muscle - adipokines, myokines and adipose/muscle cross-talk.Arch Physiol Biochem. 2011 May;117(2):47-56. doi: 10.3109/13813455.2010.535835. Epub 2010 Dec 15. Arch Physiol Biochem. 2011. PMID: 21158485 Review.
-
Chemerin Isoforms and Activity in Obesity.Int J Mol Sci. 2019 Mar 5;20(5):1128. doi: 10.3390/ijms20051128. Int J Mol Sci. 2019. PMID: 30841637 Free PMC article. Review.
Cited by
-
Chemerin Levels in Individuals with Type 2 Diabetes and a Normal Weight versus Individuals with Type 2 Diabetes and Obesity: An Observational, Cross-Sectional Study.Biomedicines. 2024 Apr 30;12(5):983. doi: 10.3390/biomedicines12050983. Biomedicines. 2024. PMID: 38790945 Free PMC article.
-
Chemerin promotes invasion of oral squamous cell carcinoma by stimulating IL-6 and TNF-α production via STAT3 activation.Mol Biol Rep. 2024 Mar 23;51(1):436. doi: 10.1007/s11033-024-09359-y. Mol Biol Rep. 2024. PMID: 38520551
-
Adipo-oncology: adipocyte-derived factors govern engraftment, survival, and progression of metastatic cancers.Cell Commun Signal. 2024 Jan 18;22(1):52. doi: 10.1186/s12964-024-01474-4. Cell Commun Signal. 2024. PMID: 38238841 Free PMC article. Review.
-
Interaction between Selected Adipokines and Musculoskeletal and Cardiovascular Systems: A Review of Current Knowledge.Int J Mol Sci. 2023 Dec 9;24(24):17287. doi: 10.3390/ijms242417287. Int J Mol Sci. 2023. PMID: 38139115 Free PMC article. Review.
-
Understanding the Consequences of Fatty Bone and Fatty Muscle: How the Osteosarcopenic Adiposity Phenotype Uncovers the Deterioration of Body Composition.Metabolites. 2023 Oct 7;13(10):1056. doi: 10.3390/metabo13101056. Metabolites. 2023. PMID: 37887382 Free PMC article. Review.
References
-
- Bosello O, Zamboni M: Visceral obesity and metabolic syndrome. Obes Rev 2000; 1: 47– 56 - PubMed
-
- Grundy SM, Brewer HB, Jr, Cleeman JI, Smith SC, Jr, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433– 438 - PubMed
-
- Bloomgarden ZT: Obesity and diabetes. Diabetes Care 2000; 23: 1584– 1590 - PubMed
-
- Felber JP, Golay A: Pathways from obesity to diabetes. Int J Obes Relat Metab Disord 2002; 26 ( Suppl. 2): S39– S45 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous